FDA Clearance for Industry’s First Orthopedic Suture-Based Fixation System
Via Surgical Receives FDA Clearance for Industry’s First Orthopedic Suture-Based Fixation System
July 1, 2021
LEARN MORE
Via Surgical Raises Funding from Catcher Technology to Accelerate Growth
March 23, 2021
LEARN MORE
Via Surgical Raises Funding from Catcher Technology to Accelerate Growth.
Top 10 Surgical Solution for Via’s soft tissue fixation system
November 25, 2019
LEARN MORE
Via Surgical’s soft tissue fixation system was voted as the Top 10 Surgical Solution by MedTech Outlook Review.
Via Surgical Receives FDA Clearance for Its FasTouch™ Absorbable Fixation System
March 18, 2019
LEARN MORE
Via Surgical Ltd, a leading developer of surgical fixation solutions, today announced U.S. Food and Drug Administration 510(k) clearance of the FasTouch™ Absorbable Fixation System.
Via Surgical Ltd. Announces the Appointment of Morris E. Franklin Jr., M.D., F.A.C.S. as Medical Advisor
March 15, 2016
LEARN MORE
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today that it has appointed Morris E. Franklin Jr., M.D., F.A.C.S. as Medical Advisor.
Via Surgical Ltd., Closes $6M Investment Led by Benslie Investment Group
February 6, 2016
LEARN MORE
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today the company has secured a $6M investment led by Benslie investment group.
Schedule a demo
Click below to schedule a demo or have a sales rep contact you
